Stock Research: Faes Farma,

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Faes Farma,

BME:FAE ES0134950F36
87
  • Value
    68
  • Growth
    52
  • Safety
    Safety
    98
  • Combined
    96
  • Sentiment
    44
  • 360° View
    360° View
    87
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Faes Farma SA is a Spain-based pharmaceutical company that researches, produces, distributes, and sells drugs, supplements, and personal care treatments, as well as raw materials. Key businesses include prescription and generic drugs, OTC medicines, food supplements, personal care, and animal nutrition products. The company operates in Spain, Portugal, Chile, and Mexico. In the last fiscal year, the company had 1775 employees, a market cap of $1676 million, profits of $338 million, and revenue of $511 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 8-Jan-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
68 86 89 98
Growth
52 35 5 9
Safety
Safety
98 93 94 92
Sentiment
44 85 38 32
360° View
360° View
87 93 70 66
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
31 5 11 31
Opinions Change
50 72 50 23
Pro Holdings
n/a 100 100 78
Market Pulse
24 84 31 35
Sentiment
44 85 38 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
68 86 89 98
Growth
52 35 5 9
Safety Safety
98 93 94 92
Combined
96 87 78 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
42 45 63 77
Price vs. Earnings (P/E)
52 72 78 85
Price vs. Book (P/B)
57 61 76 71
Dividend Yield
65 91 86 96
Value
68 86 89 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
94 23 16 10
Profit Growth
15 45 48 41
Capital Growth
1 27 1 16
Stock Returns
87 79 38 46
Growth
52 35 5 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
92 87 80 79
Refinancing
57 52 73 72
Liquidity
97 92 98 96
Safety Safety
98 93 94 92

Similar Stocks

Discover high‑ranked alternatives to Faes Farma, and broaden your portfolio horizons.

BMW

XTRA:BMW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Krka

LJSE:KRKG
Country: Slovenia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Polski Koncern Naftowy ORLEN Spolka Akcyjna

WSE:PKN
Country: Poland
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

Prosus

ENXTAM:PRX
Country: Netherlands
Industry: Internet Retail
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This stock has excellent financial qualities (value, growth, and safety are high) but a negative professional market sentiment. It suits an investor who believes the negative sentiment is a temporary overreaction and is looking for a financially solid company.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: